Mefloquine is effective in the prevention and treatment of malaria and is licensed for use by the Medicines and Healthcare products Regulatory Agency, which regulates medication in the UK. Bodies such as the Advisory Committee on Malaria Prevention, the World Health Organization and the United States Centers for Disease Control and Prevention continue to include mefloquine as an option for malaria chemoprophylaxis.<\/p>
<\/p>
The current product information for mefloquine states that neuropsychiatric adverse reactions may occur during treatment and includes warnings and precautions to minimise these risks. It also states that such adverse reactions may persist for months, or longer, even after discontinuation of the drug. It has not been established, however, that such adverse reactions may be permanent.<\/p>
<\/p>
For these reasons, there are no plans to add an addendum to the Defence Mental Health and Wellbeing Strategy Report 2017-2022.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/2000", "label" : {"_value" : "Biography information for Earl Howe"} } , "answeringMemberPrinted" : {"_value" : "Earl Howe"} , "dateOfAnswer" : {"_value" : "2018-01-30", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL4830"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-01-30T16:55:22.59Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "11"} , "answeringDeptShortName" : {"_value" : "Defence"} , "answeringDeptSortName" : {"_value" : "Defence"} , "date" : {"_value" : "2018-01-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Armed Forces: Mefloquine"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government whether the Surgeon General of Her Majesty\u2019s Armed Forces recognises the chronic neurotoxic effects on members of the Armed Forces and Veterans from the administration of mefloquine (Lariam); and whether they will be addressing the problems caused by those effects in the near future.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"} } , "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"} ], "uin" : "HL4829"} , {"_about" : "http://data.parliament.uk/resources/675754", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/675754/answer", "answerText" : {"_value" : "
On 23 January 2017, at the Committee stage of the Health Service Medical Supplies (Costs) Bill, I agreed to meet with the noble Lord to discuss clinical pharmacologists and other issues raised about the Bill. I intend to take that opportunity to discuss what further action is required and whether we should speak to other organisations.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"} } , "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"} , "dateOfAnswer" : {"_value" : "2017-01-27", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-01-27T12:09:47.153Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-01-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Clinical Pharmacologists: Training"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government whether they will convene a meeting between Health Education England, the British Pharmacological Society and the Specialist Advisory Committee for Clinical Pharmacology, which is convened under the auspices of the Royal College of Physicians, to discuss the role and importance of clinical pharmacologists and whether action is needed to prevent a fall in the number of posts and training grades.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"} } , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"} ], "uin" : "HL4829"} , {"_about" : "http://data.parliament.uk/resources/443545", "AnsweringBody" : [{"_value" : "Foreign and Commonwealth Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/443545/answer", "answerText" : {"_value" : "
The British Government has received a number of recent representations on these issues from Parliament and members of the public and is responding in writing.<\/p>
We condemn in the strongest possible terms the atrocities committed by Daesh against all civilians, including Christians, Mandeans, Yazidis, and other minorities, as well as the majority Muslim population who continue to bear the brunt of Daesh\u2019s brutality. The UK has led efforts within the UN to tackle and condemn Daesh and on the protection of civilians more widely. For example, we co-sponsored the UN Human Rights Council Resolution mandating the UN to investigate and report on Daesh abuses.<\/p>
It is a long-standing Government policy that any judgements on whether genocide has occurred are a matter for the international judicial system rather than governments or other non-judicial bodies.<\/p>
Ultimately, the only way to protect Christians, Yazidis and other minorities in the region from Daesh is by defeating this terrible organisation, which in turn requires, amongst other things, ending the conflict in Syria. The Prime Minister, my right hon. Friend the Member for Witney (Mr Cameron), set out the UK\u2019s comprehensive strategy for defeating Daesh and finding a political settlement to the Syria conflict in his response to the Foreign Affairs Committee on 26 November 2015.<\/p>
The joint Office of the United Nations Special Adviser on the Prevention of Genocide and the Special Adviser on the Responsibility to Protect (the Office) are engaged with these issues and publish much of their activity online, including statements in relation to the situation of Christians and other minorities in Syria and Iraq. Our officials maintain regular contact with officials from the Office to discuss issues related to the prevention of genocide and mass atrocities. The Government provides funding for the Office, including for their work with religious leaders and faith based organisations in the Middle East and North Africa region, aimed at the prevention of incitement to violence that could lead to atrocity crimes.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3474", "label" : {"_value" : "Biography information for Baroness Anelay of St Johns"} } , "answeringMemberPrinted" : {"_value" : "Baroness Anelay of St Johns"} , "dateOfAnswer" : {"_value" : "2016-01-22", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "HL4827"} , {"_value" : "HL4830"} , {"_value" : "HL4831"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-01-22T13:57:34.343Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "16"} , "answeringDeptShortName" : {"_value" : "Foreign and Commonwealth Office"} , "answeringDeptSortName" : {"_value" : "Foreign and Commonwealth Office"} , "date" : {"_value" : "2016-01-11", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Islamic State"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government whether they have any plans to meet the United Nations Special Advisor on the Prevention of Genocide to discuss the situation of Christians and Yazidis in Syria and Iraq.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"} } , "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"} ], "uin" : "HL4829"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 3, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }